DNLI
Price
$16.71
Change
+$0.65 (+4.05%)
Updated
May 2, 02:40 PM (EDT)
Capitalization
2.33B
11 days until earnings call
ELVN
Price
$20.52
Change
+$0.67 (+3.38%)
Updated
May 2, 02:36 PM (EDT)
Capitalization
973.96M
6 days until earnings call
Ad is loading...

DNLI vs ELVN

Header iconDNLI vs ELVN Comparison
Open Charts DNLI vs ELVNBanner chart's image
Denali Therapeutics
Price$16.71
Change+$0.65 (+4.05%)
Volume$1.32K
Capitalization2.33B
Enliven Therapeutics
Price$20.52
Change+$0.67 (+3.38%)
Volume$100
Capitalization973.96M
DNLI vs ELVN Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. ELVN commentary
May 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Buy and ELVN is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 02, 2025
Stock price -- (DNLI: $16.06 vs. ELVN: $19.85)
Brand notoriety: DNLI and ELVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 75% vs. ELVN: 76%
Market capitalization -- DNLI: $2.33B vs. ELVN: $973.96M
DNLI [@Biotechnology] is valued at $2.33B. ELVN’s [@Biotechnology] market capitalization is $973.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileELVN’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • ELVN’s FA Score: 0 green, 5 red.
According to our system of comparison, both DNLI and ELVN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 5 TA indicator(s) are bullish while ELVN’s TA Score has 6 bullish TA indicator(s).

  • DNLI’s TA Score: 5 bullish, 5 bearish.
  • ELVN’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, ELVN is a better buy in the short-term than DNLI.

Price Growth

DNLI (@Biotechnology) experienced а +3.68% price change this week, while ELVN (@Biotechnology) price change was +8.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.57%. For the same industry, the average monthly price growth was +8.32%, and the average quarterly price growth was -5.52%.

Reported Earning Dates

DNLI is expected to report earnings on Jul 31, 2025.

ELVN is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.33B) has a higher market cap than ELVN($974M). ELVN YTD gains are higher at: -11.778 vs. DNLI (-21.197). ELVN has higher annual earnings (EBITDA): -104.24M vs. DNLI (-492.89M). DNLI has more cash in the bank: 832M vs. ELVN (313M). ELVN has less debt than DNLI: ELVN (0) vs DNLI (48.7M). DNLI (0) and ELVN (0) have equivalent revenues.
DNLIELVNDNLI / ELVN
Capitalization2.33B974M240%
EBITDA-492.89M-104.24M473%
Gain YTD-21.197-11.778180%
P/E RatioN/AN/A-
Revenue00-
Total Cash832M313M266%
Total Debt48.7M0-
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
39
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIELVN
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 17 days ago
80%
Bearish Trend 17 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYBOX53.99N/A
N/A
Rydex Biotechnology A
VFWAX38.81N/A
N/A
Vanguard FTSE All-Wld ex-US Idx Admiral
LRSTX18.26N/A
N/A
Lord Abbett Small Cap Value R5
BKBDX11.97N/A
N/A
BlackRock Global Dividend K
ABLYX25.39-0.02
-0.08%
American Beacon Large Cap Value Y

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
-3.54%
BEAM - DNLI
59%
Loosely correlated
-0.50%
RCKT - DNLI
57%
Loosely correlated
+3.01%
ARWR - DNLI
56%
Loosely correlated
+1.08%
NTLA - DNLI
56%
Loosely correlated
-2.59%
RGNX - DNLI
56%
Loosely correlated
+2.29%
More

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with APGE. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then APGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
+4.80%
APGE - ELVN
51%
Loosely correlated
-0.13%
OCUL - ELVN
50%
Loosely correlated
+2.77%
ERAS - ELVN
50%
Loosely correlated
+2.05%
CRNX - ELVN
48%
Loosely correlated
+0.39%
COGT - ELVN
48%
Loosely correlated
+8.06%
More